menu
    • menu

    Looking for excipients offered by DKSH? Find information on DKSH's regulatory filings (DMFs), cGMP inspections, pricing availability, etc. on PharmaCompass.

    DKSH-PSE
    News
    DKSH-PacBio Partner for Long-Read Sequencing Access in Australia

    29 Jul 2025

    // PRESS RELEASE

    DKSH Expands Exclusive Exsymol Distribution Deal in South Korea

    24 Jul 2025

    // PRESS RELEASE

    DKSH Technology Acquires Eppendorf's Direct Thailand Operations

    21 Jul 2025

    // PRESS RELEASE

    DATA COMPILATION
    #PharmaFlow

    DKSH

    Contact Supplier

    Website

    CPhI WW Frankfurt

    Booth #8.0P66

    Book a meeting

    envelop Contact Supplier

    Latest Content

    https://www.youtube.com/embed/Z2h5A9ppOSo

    EVENTS

    DIGITAL CONTENT

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    INTERMEDIATES

    Key Products KEY PRODUCTS

    EXCIPIENTS

    Key Products KEY EXCIPIENTS

    EXCIPIENTS BY INGREDIENTS

    EXCIPIENTS BY APPLICATIONS

    INSPECTIONS & REGISTRATIONS

    PharmaCompass

    DKSH is your trusted partner for companies looking to grow their business in Asia & beyond.

    Related CompaniesRelated Companies

    About

    DKSH, founded with the goal of improving people's lives, assists businesses with market expansion and business growth in both existing and emerging markets. It has been fostering growth for businesses in Asia and beyond for over 155 years. DKSH operates in 36 markets, is listed on the SIX Swiss Exchange, employs 33,100 specialists, and generated net sales of CHF 11.1 billion in 2021. It is the leading global distributor of innovative pharma ingredients for pharmaceutical synthesis and formulation. It offers a range of products, ranging from animal care products to packaging materials, intermediates to nutraceuticals, and APIs to excipients.

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    DKSHSwitzerland Flag
    Country
    Country
    Switzerland
    Address
    Address
    Wiesenstrasse 8, P.O. Box 888 Zurich, Zurich 8034, CH
    Telephone
    Telephone
    +49 4037473411
    Client Email
    Email
    rio.chang@dksh.com
    Client Website
    Website
    https://www.dkshdiscover.com/en
    Linkedin
    Linkedin
    https://www.linkedin.com/company/dksh
    youtube
    YouTube
    http://www.youtube.com/@DkshGroup
    Twitter
    Twitter
    https://x.com/dkshgroup
    Contact Info
    Others

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    CPhI WW Frankfurt

    Booth #8.0P66

    envelop Contact Supplier

    CPhI WW Frankfurt

    Contact Supplier

    Meeting

    Digital content read-more

    Explore the latest content creation from this company

    CORPORATE CONTENT #SupplierSpotlight

    Product List 2024

    read-more

      https://www.pharmacompass.com/pdf/party/content/dksh-party-content-34131.pdf

      Open PDFOpen PDF
      UploadUpload
      Key ShareShare

    Corporate Presentation

    read-more

      https://www.pharmacompass.com/pdf/party/content/dksh-party-content-29458.pdf

      Open PDFOpen PDF
      UploadUpload
      Key ShareShare

    Performance Materials Brochure 2024

    read-more

      https://www.pharmacompass.com/pdf/party/content/dksh-party-content-13675.pdf

      Open PDFOpen PDF
      UploadUpload
      Key ShareShare

    DATA COMPILATION #PharmaFlow

    read-more
    read-more
    FDA approves record eight biosimilars in H1 2024; okays first interchangeable biosimilars for Eylea

    FDA approves record eight biosimilars in H1 2024; okays first interchangeable biosimilars for Eylea

    Biologics, or complex drugs that are derived from living organisms, have revolutionized treatment of various conditions such as cancer, autoimmune diseases, and chronic illnesses. In 2023, eight out of 10 of the world’s top-selling drugs were biologics, including Merck’s Keytruda, AbbVie’s Humira, and Sanofi’s Dupixent.Due to their high costs, accessibility of biologics has been a challenge. That’s why biosimilars, or game-changing copycats of biologics that provide highly similar yet more affordable alternatives to established biologics, are becoming popular.The first biosimilar — Sandoz’ Zarxio — was approved by the US Food and Drug Administration (FDA) in 2015. Its reference biologic was Amgen’s Neupogen (filgrastim).  Since then, the global market for biosimilars has been growing at an impressive pace — between 2015 and 2020, it grew at a whopping compounded annual growth rate (CAGR) of 78 percent, touching US$ 17.9 billion in size. It is expected to continue growing at a CAGR of 15 percent and reach a size of about US$ 75 billion by 2030.Major biosimilar players include Amgen, Sandoz, Samsung Bioepis, Pfizer, Biocon Biologics, Celltrion, Stada Arzneimittel, Accord Healthcare, Fresenius Kabi, Coherus Biosciences, Apotex, and Sanofi. The increasing demand for biosimilars has propelled growth in contract manufacturing. Some of the leading contract manufacturing organizations (CMOs) and contract development and manufacturing organizations (CDMOs) that manufacture biosimilars are Polpharma Biologics, Catalent, Pfizer CentreOne, Lonza, Boehringer Ingelheim BioXcellence, Thermo Fisher Scientific, WuXi Biologics, and FUJIFILM Diosynth Biotechnologies.Access the Interactive Dashboard for Biosimilar Developments (Free Excel)Amgen, Sandoz top list of ‘approved biosimilars’; FDA okays 8 copycats in H1 2024Over the recent years, regulatory agencies like the FDA and the European Medicines Agency (EMA) have established rigorous approval pathways for biosimilars.Since 2015,  FDA has approved 53 biosimilars, while the EMA has approved 86 biosimilars. Among the US, European and Canadian markets, Amgen and Sandoz are tied in the first place with 13 approved biosimilars each. Samsung Biologics has nine approved biosimilars, followed by Pfizer with eight and Biocon Biologics with seven. In the first half of this year, FDA set a record by approving eight biosimilars — the highest for H1 of any year. EMA has okayed six biosimilars so far in 2024.In 2023, five biosimilars were approved by the FDA with just one being okayed in the first half. The year marked the end of exclusivity for Humira after 20 years, in which it netted a total of US$ 200 billion in sales. AbbVie’s flagship autoimmune drug has a record 10 biosimilars.Johnson & Johnson’s Stelara also lost exclusivity in 2023 and as many as 11 drugmakers hope to bring its biosimilars to the market. Amgen’s Wezlana was the first biosimilar to Stelara, and it was approved as interchangeable by FDA in October last year.Access the Interactive Dashboard for Biosimilar Developments (Free Excel) FDA approves first interchangeable biosimilar for Eylea, cuts regulatory feeDeveloping a biosimilar costs both money and time. According to Pfizer, developing a biosimilar can take five to nine years and cost over US$ 100 million, not including regulatory fees.In October 2023, FDA slashed its fees with the program fee at US$ 177,397, down from US$ 304,162. The application fees for products that require clinical data has been set at US$ 1,018,753, down from US$ 1,746,745. The application fee for products that don’t require clinical data has been set lower — at US$ 509,377 —  down from US$ 873,373 set earlier. This reduction in application fee has propelled demand for contract manufacturing of biosimilars.There has also been a rise in approvals of interchangeable biosimilars this year. Interchangeable biosimilars meet additional requirements and may be substituted for its reference product by a pharmacist without consulting the prescriber. This year saw FDA approve the first interchangeable biosimilars for bone cancer drug denosumab (Prolia and Xgeva) in Jubbonti and Wyost as well as for eculizumab (Soliris) in Bkemv.In May, FDA approved the first interchangeable biosimilars for eye drug aflibercept (Eylea) in Opuviz and Yesafili. Other biosimilars approved in 2024 include Simlandi for adalimumab (Humira), Tyenne for tocilizumab (Actemra), Selarsdi for ustekinumab (Stelara), and Hercessi for trastuzumab (Herceptin).Access the Interactive Dashboard for Biosimilar Developments (Free Excel) Merck’s Keytruda, BMS’ Opdivo, Novartis’ Cosentyx brace for biosimilar competitionHealthcare spending in the US is projected to rise from US$ 4.5 trillion in 2022 to US$ 6 trillion by 2027. While biologics involve just two percent of prescriptions, they account for 46 percent of all pharmaceutical spending. In 2022, US$ 252 billion was spent on biologics.Biosimilar-related savings in 2023 were estimated to be US$ 9.4 billion in the US and € 10 billion (US$ 10.68 billion) in Europe. With expensive and widely used drugs like AbbVie’s Humira, J&J’s Stelara, and Regeneron’s Eylea coming under competition, US savings are projected to reach US$ 181 billion through 2027. Between 2026 and 2032, about 39 blockbusters are set to lose exclusivity in the US and Europe. Merck’s Keytruda (pembrolizumab) was the world’s top-selling drug last year, generating US$ 25 billion in sales. Its patent is set to expire in 2028 with sales expected to drop 19 percent to US$ 27.4 billion in 2029 from US$ 33.7 billion the previous year. Samsung Bioepis and Amgen initiated phase 3 trials of pembrolizumab in April and May of this year, respectively.Opdivo (nivolumab), belonging to the same class of drugs, competes with Keytruda and is also set to lose patent protection in 2028. It hauled in US$ 10 billion in total global sales in 2023 for Bristol Myers Squibb. The key patents of Novartis’ Cosentyx (secukinumab) are set to expire between 2025 and 2026. Cosentyx saw sales of US$ 5 billion in 2023. Taizhou Mabtech Pharmaceutical and Bio-Thera Solutions are conducting phase 3 trials of secukinumab.Access the Interactive Dashboard for Biosimilar Developments (Free Excel) Our viewWith over 2 billion people worldwide unable to access life-saving medicines, biosimilars hold the key to healthcare accessibility. In 2023, a record 13 biosimilars were launched in the market — the highest for a single year. And this included nine much-anticipated biosimilars to AbbVie’s Humira.  In April this year, FDA announced a Biosimilars Action Plan to streamline the development of biosimilars. With a sharp focus on biosimilars, we expect more records to be broken in the near term. New launches of biosimilars to drugs like J&J’s Stelara, Regeneron’s Eylea and Merck’s Keytruda will surely help in creating new records.
    subscribeSubscribe
    ExcelExcel Download

    Impressions: 3322

    https://www.pharmacompass.com/radio-compass-blog/fda-approves-record-eight-biosimilars-in-h1-2024-okays-first-interchangeable-biosimilars-for-eylea

    #PharmaFlow by PHARMACOMPASS
    27 Jun 2024
    Share Share

    NEWS #PharmaBuzz

    read-more
    read-more
    DKSH-PacBio Partner for Long-Read Sequencing Access in Australia
    DKSH-PacBio Partner for Long-Read Sequencing Access in Australia

    29 Jul 2025

    // PRESS RELEASE

    https://www.dksh.com/global-en/home/media/news/dksh-and-pacbio-announce-exclusive-partnership-to-expand-access-to-high-fidelity-long-read-sequencing-in-australia?redirect=/media/news

    PRESS RELEASE
    29 Jul 2025
    Share Share
    DKSH Expands Exclusive Exsymol Distribution Deal in South Korea
    DKSH Expands Exclusive Exsymol Distribution Deal in South Korea

    24 Jul 2025

    // PRESS RELEASE

    https://www.dksh.com/global-en/home/media/news/dksh-expands-exclusive-distribution-agreement-with-exsymol-in-south-korea?redirect=/media/news

    PRESS RELEASE
    24 Jul 2025
    Share Share
    DKSH Technology Acquires Eppendorf's Direct Thailand Operations
    DKSH Technology Acquires Eppendorf's Direct Thailand Operations

    21 Jul 2025

    // PRESS RELEASE

    https://www.dksh.com/global-en/home/investors/investor-news/dksh-technology-to-acquire-eppendorf-s-direct-presence-in-thailand?redirect=/media/news

    PRESS RELEASE
    21 Jul 2025
    Share Share
    DKSH and Bayer Join Forces in Southeast Asia Markets
    DKSH and Bayer Join Forces in Southeast Asia Markets

    12 Jul 2025

    // PRESS RELEASE

    https://www.dksh.com/global-en/home/media/news/dksh-and-bayer-launch-strategic-partnership-across-multiple-markets-in-southeast-asia

    PRESS RELEASE
    12 Jul 2025
    Share Share
    DKSH-Bayer Launch Strategic Partnership Across Southeast Asia
    DKSH-Bayer Launch Strategic Partnership Across Southeast Asia

    10 Jul 2025

    // PRESS RELEASE

    https://www.dksh.com/global-en/home/media/news/dksh-and-bayer-launch-strategic-partnership-across-multiple-markets-in-southeast-asia?redirect=/media/news

    PRESS RELEASE
    10 Jul 2025
    Share Share
    DKSH Singapore Gets Donanemab Approval for Early Alzheimer's
    DKSH Singapore Gets Donanemab Approval for Early Alzheimer's

    09 Jul 2025

    // PRESS RELEASE

    https://www.dksh.com/global-en/home/media/news/dksh-singapore-receives-approval-of-donanemab-for-the-treatment-of-early-symptomatic-alzheimer-s-disease?redirect=/media/news

    PRESS RELEASE
    09 Jul 2025
    Share Share

    LISTED APIs

    read-more
    read-more
    Contact Supplier
    • FDA
    • fda
    • EDQM
    • WHO-GMP
    Virtual BoothDKSH is your trusted partner for companies looking to grow their business in Asia & beyond.

    Ajmaline

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    DKSH, founded with the goal of improving people's lives, assists businesses with market expansion and business growth in both existing and emerging markets. It has been fostering growth for businesses in Asia and beyond for over 155 years. DKSH operates in 36 markets, is listed on the SIX Swiss Exchange, employs 33,100 specialists, and generated ne...
    DKSH, founded with the goal of improving people's lives, assists businesses with market expansion and business growth in both existing and emerging markets. It has been fostering growth for businesses in Asia and beyond for over 155 years. DKSH operates in 36 markets, is listed on the SIX Swiss Exchange, employs 33,100 specialists, and generated net sales of CHF 11.1 billion in 2021. It is the leading global distributor of innovative pharma ingredients for pharmaceutical synthesis and formulation. It offers a range of products, ranging from animal care products to packaging materials, intermediates to nutraceuticals, and APIs to excipients.
    DKSH Company Banner

    01

    Ajmaline

    Switzerland
    arrow
    CPhI WW Frankfurt
    Booth #8.0P66
    • fda
    • EDQM
    • WHO-GMP
    Virtual BoothDKSH is your trusted partner for companies looking to grow their business in Asia & beyond.

    DKSH

    DKSH, founded with the goal of improving people's lives, assists businesses with market expansion and business growth in both existing and emerging markets. It has been fostering growth for businesses in Asia and beyond for over 155 years. DKSH operates in 36 markets, is listed on the SIX Swiss Exchange, employs 33,100 specialists, and generated net sales of CHF 11.1 billion in 2021. It is the leading global distributor of innovative pharma ingredients for pharmaceutical synthesis and formulation. It offers a range of products, ranging from animal care products to packaging materials, intermediates to nutraceuticals, and APIs to excipients.

    About the Company : DKSH, founded with the goal of improving people's lives, assists businesses with market expansion and business growth in both existing and emerging markets. It has been fostering growth for busi...

    DKSH Company Banner

    Product
    Web Link

    Stock Recap
    #Pipeline Prospector

    Market
    Place

    Contact Supplier
    • FDA
    • fda
    • EDQM
    • WHO-GMP
    Virtual BoothDKSH is your trusted partner for companies looking to grow their business in Asia & beyond.

    Alpha Lipoic Acid

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    DKSH, founded with the goal of improving people's lives, assists businesses with market expansion and business growth in both existing and emerging markets. It has been fostering growth for businesses in Asia and beyond for over 155 years. DKSH operates in 36 markets, is listed on the SIX Swiss Exchange, employs 33,100 specialists, and generated ne...
    DKSH, founded with the goal of improving people's lives, assists businesses with market expansion and business growth in both existing and emerging markets. It has been fostering growth for businesses in Asia and beyond for over 155 years. DKSH operates in 36 markets, is listed on the SIX Swiss Exchange, employs 33,100 specialists, and generated net sales of CHF 11.1 billion in 2021. It is the leading global distributor of innovative pharma ingredients for pharmaceutical synthesis and formulation. It offers a range of products, ranging from animal care products to packaging materials, intermediates to nutraceuticals, and APIs to excipients.
    DKSH Company Banner

    02

    Alpha Lipoic Acid

    Switzerland
    arrow
    CPhI WW Frankfurt
    Booth #8.0P66
    • fda
    • EDQM
    • WHO-GMP
    Virtual BoothDKSH is your trusted partner for companies looking to grow their business in Asia & beyond.

    DKSH

    DKSH, founded with the goal of improving people's lives, assists businesses with market expansion and business growth in both existing and emerging markets. It has been fostering growth for businesses in Asia and beyond for over 155 years. DKSH operates in 36 markets, is listed on the SIX Swiss Exchange, employs 33,100 specialists, and generated net sales of CHF 11.1 billion in 2021. It is the leading global distributor of innovative pharma ingredients for pharmaceutical synthesis and formulation. It offers a range of products, ranging from animal care products to packaging materials, intermediates to nutraceuticals, and APIs to excipients.

    About the Company : DKSH, founded with the goal of improving people's lives, assists businesses with market expansion and business growth in both existing and emerging markets. It has been fostering growth for busi...

    DKSH Company Banner

    Product
    Web Link

    Stock Recap
    #Pipeline Prospector

    Market
    Place

    Contact Supplier
    • FDA
    • fda
    • EDQM
    • WHO-GMP
    Virtual BoothDKSH is your trusted partner for companies looking to grow their business in Asia & beyond.

    Aluminium Hydroxide

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    DKSH, founded with the goal of improving people's lives, assists businesses with market expansion and business growth in both existing and emerging markets. It has been fostering growth for businesses in Asia and beyond for over 155 years. DKSH operates in 36 markets, is listed on the SIX Swiss Exchange, employs 33,100 specialists, and generated ne...
    DKSH, founded with the goal of improving people's lives, assists businesses with market expansion and business growth in both existing and emerging markets. It has been fostering growth for businesses in Asia and beyond for over 155 years. DKSH operates in 36 markets, is listed on the SIX Swiss Exchange, employs 33,100 specialists, and generated net sales of CHF 11.1 billion in 2021. It is the leading global distributor of innovative pharma ingredients for pharmaceutical synthesis and formulation. It offers a range of products, ranging from animal care products to packaging materials, intermediates to nutraceuticals, and APIs to excipients.
    DKSH Company Banner

    03

    Aluminium Hydroxide

    Switzerland
    arrow
    CPhI WW Frankfurt
    Booth #8.0P66
    • fda
    • EDQM
    • WHO-GMP
    Virtual BoothDKSH is your trusted partner for companies looking to grow their business in Asia & beyond.

    DKSH

    DKSH, founded with the goal of improving people's lives, assists businesses with market expansion and business growth in both existing and emerging markets. It has been fostering growth for businesses in Asia and beyond for over 155 years. DKSH operates in 36 markets, is listed on the SIX Swiss Exchange, employs 33,100 specialists, and generated net sales of CHF 11.1 billion in 2021. It is the leading global distributor of innovative pharma ingredients for pharmaceutical synthesis and formulation. It offers a range of products, ranging from animal care products to packaging materials, intermediates to nutraceuticals, and APIs to excipients.

    About the Company : DKSH, founded with the goal of improving people's lives, assists businesses with market expansion and business growth in both existing and emerging markets. It has been fostering growth for busi...

    DKSH Company Banner

    Product
    Web Link

    Stock Recap
    #Pipeline Prospector

    Market
    Place

    Contact Supplier
    • FDA
    • fda
    • EDQM
    • WHO-GMP
    Virtual BoothDKSH is your trusted partner for companies looking to grow their business in Asia & beyond.

    Amiodarone Hydrochloride

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    DKSH, founded with the goal of improving people's lives, assists businesses with market expansion and business growth in both existing and emerging markets. It has been fostering growth for businesses in Asia and beyond for over 155 years. DKSH operates in 36 markets, is listed on the SIX Swiss Exchange, employs 33,100 specialists, and generated ne...
    DKSH, founded with the goal of improving people's lives, assists businesses with market expansion and business growth in both existing and emerging markets. It has been fostering growth for businesses in Asia and beyond for over 155 years. DKSH operates in 36 markets, is listed on the SIX Swiss Exchange, employs 33,100 specialists, and generated net sales of CHF 11.1 billion in 2021. It is the leading global distributor of innovative pharma ingredients for pharmaceutical synthesis and formulation. It offers a range of products, ranging from animal care products to packaging materials, intermediates to nutraceuticals, and APIs to excipients.
    DKSH Company Banner

    04

    Amiodarone Hydrochloride

    Switzerland
    arrow
    CPhI WW Frankfurt
    Booth #8.0P66
    • fda
    • EDQM
    • WHO-GMP
    Virtual BoothDKSH is your trusted partner for companies looking to grow their business in Asia & beyond.

    DKSH

    DKSH, founded with the goal of improving people's lives, assists businesses with market expansion and business growth in both existing and emerging markets. It has been fostering growth for businesses in Asia and beyond for over 155 years. DKSH operates in 36 markets, is listed on the SIX Swiss Exchange, employs 33,100 specialists, and generated net sales of CHF 11.1 billion in 2021. It is the leading global distributor of innovative pharma ingredients for pharmaceutical synthesis and formulation. It offers a range of products, ranging from animal care products to packaging materials, intermediates to nutraceuticals, and APIs to excipients.

    About the Company : DKSH, founded with the goal of improving people's lives, assists businesses with market expansion and business growth in both existing and emerging markets. It has been fostering growth for busi...

    DKSH Company Banner

    Product
    Web Link

    Stock Recap
    #Pipeline Prospector

    Market
    Place

    Contact Supplier
    • FDA
    • fda
    • EDQM
    • WHO-GMP
    Virtual BoothDKSH is your trusted partner for companies looking to grow their business in Asia & beyond.

    Apixaban

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    DKSH, founded with the goal of improving people's lives, assists businesses with market expansion and business growth in both existing and emerging markets. It has been fostering growth for businesses in Asia and beyond for over 155 years. DKSH operates in 36 markets, is listed on the SIX Swiss Exchange, employs 33,100 specialists, and generated ne...
    DKSH, founded with the goal of improving people's lives, assists businesses with market expansion and business growth in both existing and emerging markets. It has been fostering growth for businesses in Asia and beyond for over 155 years. DKSH operates in 36 markets, is listed on the SIX Swiss Exchange, employs 33,100 specialists, and generated net sales of CHF 11.1 billion in 2021. It is the leading global distributor of innovative pharma ingredients for pharmaceutical synthesis and formulation. It offers a range of products, ranging from animal care products to packaging materials, intermediates to nutraceuticals, and APIs to excipients.
    DKSH Company Banner

    05

    Apixaban

    Switzerland
    arrow
    CPhI WW Frankfurt
    Booth #8.0P66
    • fda
    • EDQM
    • WHO-GMP
    Virtual BoothDKSH is your trusted partner for companies looking to grow their business in Asia & beyond.

    DKSH

    DKSH, founded with the goal of improving people's lives, assists businesses with market expansion and business growth in both existing and emerging markets. It has been fostering growth for businesses in Asia and beyond for over 155 years. DKSH operates in 36 markets, is listed on the SIX Swiss Exchange, employs 33,100 specialists, and generated net sales of CHF 11.1 billion in 2021. It is the leading global distributor of innovative pharma ingredients for pharmaceutical synthesis and formulation. It offers a range of products, ranging from animal care products to packaging materials, intermediates to nutraceuticals, and APIs to excipients.

    About the Company : DKSH, founded with the goal of improving people's lives, assists businesses with market expansion and business growth in both existing and emerging markets. It has been fostering growth for busi...

    DKSH Company Banner

    Product
    Web Link

    Stock Recap
    #Pipeline Prospector

    Market
    Place

    Contact Supplier
    • FDA
    • fda
    • EDQM
    • WHO-GMP
    Virtual BoothDKSH is your trusted partner for companies looking to grow their business in Asia & beyond.

    Artemether

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    DKSH, founded with the goal of improving people's lives, assists businesses with market expansion and business growth in both existing and emerging markets. It has been fostering growth for businesses in Asia and beyond for over 155 years. DKSH operates in 36 markets, is listed on the SIX Swiss Exchange, employs 33,100 specialists, and generated ne...
    DKSH, founded with the goal of improving people's lives, assists businesses with market expansion and business growth in both existing and emerging markets. It has been fostering growth for businesses in Asia and beyond for over 155 years. DKSH operates in 36 markets, is listed on the SIX Swiss Exchange, employs 33,100 specialists, and generated net sales of CHF 11.1 billion in 2021. It is the leading global distributor of innovative pharma ingredients for pharmaceutical synthesis and formulation. It offers a range of products, ranging from animal care products to packaging materials, intermediates to nutraceuticals, and APIs to excipients.
    DKSH Company Banner

    06

    Artemether

    Switzerland
    arrow
    CPhI WW Frankfurt
    Booth #8.0P66
    • fda
    • EDQM
    • WHO-GMP
    Virtual BoothDKSH is your trusted partner for companies looking to grow their business in Asia & beyond.

    DKSH

    DKSH, founded with the goal of improving people's lives, assists businesses with market expansion and business growth in both existing and emerging markets. It has been fostering growth for businesses in Asia and beyond for over 155 years. DKSH operates in 36 markets, is listed on the SIX Swiss Exchange, employs 33,100 specialists, and generated net sales of CHF 11.1 billion in 2021. It is the leading global distributor of innovative pharma ingredients for pharmaceutical synthesis and formulation. It offers a range of products, ranging from animal care products to packaging materials, intermediates to nutraceuticals, and APIs to excipients.

    About the Company : DKSH, founded with the goal of improving people's lives, assists businesses with market expansion and business growth in both existing and emerging markets. It has been fostering growth for busi...

    DKSH Company Banner

    Product
    Web Link

    Stock Recap
    #Pipeline Prospector

    Market
    Place

    Contact Supplier
    • FDA
    • fda
    • EDQM
    • WHO-GMP
    Virtual BoothDKSH is your trusted partner for companies looking to grow their business in Asia & beyond.

    Aspirin

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    DKSH, founded with the goal of improving people's lives, assists businesses with market expansion and business growth in both existing and emerging markets. It has been fostering growth for businesses in Asia and beyond for over 155 years. DKSH operates in 36 markets, is listed on the SIX Swiss Exchange, employs 33,100 specialists, and generated ne...
    DKSH, founded with the goal of improving people's lives, assists businesses with market expansion and business growth in both existing and emerging markets. It has been fostering growth for businesses in Asia and beyond for over 155 years. DKSH operates in 36 markets, is listed on the SIX Swiss Exchange, employs 33,100 specialists, and generated net sales of CHF 11.1 billion in 2021. It is the leading global distributor of innovative pharma ingredients for pharmaceutical synthesis and formulation. It offers a range of products, ranging from animal care products to packaging materials, intermediates to nutraceuticals, and APIs to excipients.
    DKSH Company Banner

    07

    Aspirin

    Switzerland
    arrow
    CPhI WW Frankfurt
    Booth #8.0P66
    • fda
    • EDQM
    • WHO-GMP
    Virtual BoothDKSH is your trusted partner for companies looking to grow their business in Asia & beyond.

    DKSH

    DKSH, founded with the goal of improving people's lives, assists businesses with market expansion and business growth in both existing and emerging markets. It has been fostering growth for businesses in Asia and beyond for over 155 years. DKSH operates in 36 markets, is listed on the SIX Swiss Exchange, employs 33,100 specialists, and generated net sales of CHF 11.1 billion in 2021. It is the leading global distributor of innovative pharma ingredients for pharmaceutical synthesis and formulation. It offers a range of products, ranging from animal care products to packaging materials, intermediates to nutraceuticals, and APIs to excipients.

    About the Company : DKSH, founded with the goal of improving people's lives, assists businesses with market expansion and business growth in both existing and emerging markets. It has been fostering growth for busi...

    DKSH Company Banner

    Product
    Web Link

    Stock Recap
    #Pipeline Prospector

    Market
    Place

    Contact Supplier
    • FDA
    • fda
    • EDQM
    • WHO-GMP
    Virtual BoothDKSH is your trusted partner for companies looking to grow their business in Asia & beyond.

    Atorvastatin

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    DKSH, founded with the goal of improving people's lives, assists businesses with market expansion and business growth in both existing and emerging markets. It has been fostering growth for businesses in Asia and beyond for over 155 years. DKSH operates in 36 markets, is listed on the SIX Swiss Exchange, employs 33,100 specialists, and generated ne...
    DKSH, founded with the goal of improving people's lives, assists businesses with market expansion and business growth in both existing and emerging markets. It has been fostering growth for businesses in Asia and beyond for over 155 years. DKSH operates in 36 markets, is listed on the SIX Swiss Exchange, employs 33,100 specialists, and generated net sales of CHF 11.1 billion in 2021. It is the leading global distributor of innovative pharma ingredients for pharmaceutical synthesis and formulation. It offers a range of products, ranging from animal care products to packaging materials, intermediates to nutraceuticals, and APIs to excipients.
    DKSH Company Banner

    08

    Atorvastatin

    Switzerland
    arrow
    CPhI WW Frankfurt
    Booth #8.0P66
    • fda
    • EDQM
    • WHO-GMP
    Virtual BoothDKSH is your trusted partner for companies looking to grow their business in Asia & beyond.

    DKSH

    DKSH, founded with the goal of improving people's lives, assists businesses with market expansion and business growth in both existing and emerging markets. It has been fostering growth for businesses in Asia and beyond for over 155 years. DKSH operates in 36 markets, is listed on the SIX Swiss Exchange, employs 33,100 specialists, and generated net sales of CHF 11.1 billion in 2021. It is the leading global distributor of innovative pharma ingredients for pharmaceutical synthesis and formulation. It offers a range of products, ranging from animal care products to packaging materials, intermediates to nutraceuticals, and APIs to excipients.

    About the Company : DKSH, founded with the goal of improving people's lives, assists businesses with market expansion and business growth in both existing and emerging markets. It has been fostering growth for busi...

    DKSH Company Banner

    Product
    Web Link

    Stock Recap
    #Pipeline Prospector

    Market
    Place

    Contact Supplier
    • FDA
    • fda
    • EDQM
    • WHO-GMP
    Virtual BoothDKSH is your trusted partner for companies looking to grow their business in Asia & beyond.

    Atracurium Besylate

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    DKSH, founded with the goal of improving people's lives, assists businesses with market expansion and business growth in both existing and emerging markets. It has been fostering growth for businesses in Asia and beyond for over 155 years. DKSH operates in 36 markets, is listed on the SIX Swiss Exchange, employs 33,100 specialists, and generated ne...
    DKSH, founded with the goal of improving people's lives, assists businesses with market expansion and business growth in both existing and emerging markets. It has been fostering growth for businesses in Asia and beyond for over 155 years. DKSH operates in 36 markets, is listed on the SIX Swiss Exchange, employs 33,100 specialists, and generated net sales of CHF 11.1 billion in 2021. It is the leading global distributor of innovative pharma ingredients for pharmaceutical synthesis and formulation. It offers a range of products, ranging from animal care products to packaging materials, intermediates to nutraceuticals, and APIs to excipients.
    DKSH Company Banner

    09

    Atracurium Besylate

    Switzerland
    arrow
    CPhI WW Frankfurt
    Booth #8.0P66
    • fda
    • EDQM
    • WHO-GMP
    Virtual BoothDKSH is your trusted partner for companies looking to grow their business in Asia & beyond.

    DKSH

    DKSH, founded with the goal of improving people's lives, assists businesses with market expansion and business growth in both existing and emerging markets. It has been fostering growth for businesses in Asia and beyond for over 155 years. DKSH operates in 36 markets, is listed on the SIX Swiss Exchange, employs 33,100 specialists, and generated net sales of CHF 11.1 billion in 2021. It is the leading global distributor of innovative pharma ingredients for pharmaceutical synthesis and formulation. It offers a range of products, ranging from animal care products to packaging materials, intermediates to nutraceuticals, and APIs to excipients.

    About the Company : DKSH, founded with the goal of improving people's lives, assists businesses with market expansion and business growth in both existing and emerging markets. It has been fostering growth for busi...

    DKSH Company Banner

    Product
    Web Link

    Stock Recap
    #Pipeline Prospector

    Market
    Place

    Contact Supplier
    • FDA
    • fda
    • EDQM
    • WHO-GMP
    Virtual BoothDKSH is your trusted partner for companies looking to grow their business in Asia & beyond.

    Avermectin

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    DKSH, founded with the goal of improving people's lives, assists businesses with market expansion and business growth in both existing and emerging markets. It has been fostering growth for businesses in Asia and beyond for over 155 years. DKSH operates in 36 markets, is listed on the SIX Swiss Exchange, employs 33,100 specialists, and generated ne...
    DKSH, founded with the goal of improving people's lives, assists businesses with market expansion and business growth in both existing and emerging markets. It has been fostering growth for businesses in Asia and beyond for over 155 years. DKSH operates in 36 markets, is listed on the SIX Swiss Exchange, employs 33,100 specialists, and generated net sales of CHF 11.1 billion in 2021. It is the leading global distributor of innovative pharma ingredients for pharmaceutical synthesis and formulation. It offers a range of products, ranging from animal care products to packaging materials, intermediates to nutraceuticals, and APIs to excipients.
    DKSH Company Banner

    10

    Avermectin

    Switzerland
    arrow
    CPhI WW Frankfurt
    Booth #8.0P66
    • fda
    • EDQM
    • WHO-GMP
    Virtual BoothDKSH is your trusted partner for companies looking to grow their business in Asia & beyond.

    DKSH

    DKSH, founded with the goal of improving people's lives, assists businesses with market expansion and business growth in both existing and emerging markets. It has been fostering growth for businesses in Asia and beyond for over 155 years. DKSH operates in 36 markets, is listed on the SIX Swiss Exchange, employs 33,100 specialists, and generated net sales of CHF 11.1 billion in 2021. It is the leading global distributor of innovative pharma ingredients for pharmaceutical synthesis and formulation. It offers a range of products, ranging from animal care products to packaging materials, intermediates to nutraceuticals, and APIs to excipients.

    About the Company : DKSH, founded with the goal of improving people's lives, assists businesses with market expansion and business growth in both existing and emerging markets. It has been fostering growth for busi...

    DKSH Company Banner

    Product
    Web Link

    Stock Recap
    #Pipeline Prospector

    Market
    Place

    Only 10 entries up to this point, click to access all click full view read-more
    click full view
    Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

    Drugs in Development

    read-more
    read-more
    • Deals
    • fda
    • EDQM
    • WHO-GMP
    Virtual BoothDKSH is your trusted partner for companies looking to grow their business in Asia & beyond.

    Kowa and DKSH Debut Triglycerides Lowering Medicine, Parmodia®, in Malaysia

    Details:

    DKSH will undertake the responsibility for providing comprehensive Market Expansion Services for triglycerides lowering drug, Parmodia (pemafibrate).


    Lead Product(s): Pemafibrate,Inapplicable

    Therapeutic Area: Endocrinology Brand Name: Parmodia

    Study Phase: Approved FDFProduct Type: Miscellaneous

    Recipient: Kowa Pharmaceuticals America

    Deal Size: Undisclosed Upfront Cash: Undisclosed

    Deal Type: Partnership January 24, 2025

    DKSH Company Banner

    01

    DKSH

    Switzerland
    arrow
    CPhI WW Frankfurt
    Booth #8.0P66
    • fda
    • EDQM
    • WHO-GMP
    Virtual BoothDKSH is your trusted partner for companies looking to grow their business in Asia & beyond.

    Lead Product(s) : Pemafibrate,Inapplicable

    Therapeutic Area : Endocrinology

    Highest Development Status : Approved FDF

    Recipient : Kowa Pharmaceuticals America

    Deal Size : Undisclosed

    Deal Type : Partnership

    DEALS_DEV arrow-down

    Kowa and DKSH Debut Triglycerides Lowering Medicine, Parmodia®, in Malaysia

    Details : DKSH will undertake the responsibility for providing comprehensive Market Expansion Services for triglycerides lowering drug, Parmodia (pemafibrate).

    Product Name : Parmodia

    Product Type : Miscellaneous

    Upfront Cash : Undisclosed

    January 24, 2025

    DKSH Company Banner

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow

    Virtual Booth

    • Deals
    • fda
    • EDQM
    • WHO-GMP
    Virtual BoothDKSH is your trusted partner for companies looking to grow their business in Asia & beyond.

    DKSH Supports MSD’s Expansion with New Partnership to Improve Vaccine Access in Thailand

    Details:

    DKSH will support the commercialization of human papillomavirus (HPV) vaccines, including Gardasil, in Thailand.


    Lead Product(s): HPV Quadrivalent (Types 6, 11, 16, and 18) Vaccine, Recombinant,Inapplicable

    Therapeutic Area: Infections and Infectious Diseases Brand Name: Gardasil

    Study Phase: Approved FDFProduct Type: Vaccine

    Recipient: Merck & Co

    Deal Size: Undisclosed Upfront Cash: Undisclosed

    Deal Type: Partnership December 12, 2024

    DKSH Company Banner

    02

    DKSH

    Switzerland
    arrow
    CPhI WW Frankfurt
    Booth #8.0P66
    • fda
    • EDQM
    • WHO-GMP
    Virtual BoothDKSH is your trusted partner for companies looking to grow their business in Asia & beyond.

    Lead Product(s) : HPV Quadrivalent (Types 6, 11, 16, and 18) Vaccine, Recombinant,Inapplicable

    Therapeutic Area : Infections and Infectious Diseases

    Highest Development Status : Approved FDF

    Recipient : Merck & Co

    Deal Size : Undisclosed

    Deal Type : Partnership

    DEALS_DEV arrow-down

    DKSH Supports MSD’s Expansion with New Partnership to Improve Vaccine Access in Thailand

    Details : DKSH will support the commercialization of human papillomavirus (HPV) vaccines, including Gardasil, in Thailand.

    Product Name : Gardasil

    Product Type : Vaccine

    Upfront Cash : Undisclosed

    December 12, 2024

    DKSH Company Banner

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow

    Virtual Booth

    • Deals
    • fda
    • EDQM
    • WHO-GMP
    Virtual BoothDKSH is your trusted partner for companies looking to grow their business in Asia & beyond.

    DKSH and Kyowa Kirin Forge Strategic Partnership Across Asia-Pacific

    Details:

    The partnership covers a promotion and distribution agreement for commercial rights of Kyowa’s established medicines, including Crysvita (burosumab), indicated for X-linked hypophosphatemia.


    Lead Product(s): Burosumab,Inapplicable

    Therapeutic Area: Rare Diseases and Disorders Brand Name: Crysvita

    Study Phase: Approved FDFProduct Type: Antibody, Unconjugated

    Recipient: Kyowa Kirin

    Deal Size: Undisclosed Upfront Cash: Undisclosed

    Deal Type: Partnership August 02, 2024

    DKSH Company Banner

    03

    DKSH

    Switzerland
    arrow
    CPhI WW Frankfurt
    Booth #8.0P66
    • fda
    • EDQM
    • WHO-GMP
    Virtual BoothDKSH is your trusted partner for companies looking to grow their business in Asia & beyond.

    Lead Product(s) : Burosumab,Inapplicable

    Therapeutic Area : Rare Diseases and Disorders

    Highest Development Status : Approved FDF

    Recipient : Kyowa Kirin

    Deal Size : Undisclosed

    Deal Type : Partnership

    DEALS_DEV arrow-down

    DKSH and Kyowa Kirin Forge Strategic Partnership Across Asia-Pacific

    Details : The partnership covers a promotion and distribution agreement for commercial rights of Kyowa’s established medicines, including Crysvita (burosumab), indicated for X-linked hypophosphatemia.

    Product Name : Crysvita

    Product Type : Antibody, Unconjugated

    Upfront Cash : Undisclosed

    August 02, 2024

    DKSH Company Banner

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow

    Virtual Booth

    • Deals
    • fda
    • EDQM
    • WHO-GMP
    Virtual BoothDKSH is your trusted partner for companies looking to grow their business in Asia & beyond.

    DKSH Has Successfully Entered into a Strategic Partnership with SciGen in Vietnam

    Details:

    DKSH has enetered a strategic partnership with SciGen to supply Zometa (zoledronic acid) to the Vietnamese market. it is indicated for the treatment of Advanced cancers.


    Lead Product(s): Zoledronic Acid,Inapplicable

    Therapeutic Area: Oncology Brand Name: Zometa

    Study Phase: Approved FDFProduct Type: Miscellaneous

    Recipient: SciGen

    Deal Size: Undisclosed Upfront Cash: Undisclosed

    Deal Type: Partnership July 21, 2023

    DKSH Company Banner

    04

    DKSH

    Switzerland
    arrow
    CPhI WW Frankfurt
    Booth #8.0P66
    • fda
    • EDQM
    • WHO-GMP
    Virtual BoothDKSH is your trusted partner for companies looking to grow their business in Asia & beyond.

    Lead Product(s) : Zoledronic Acid,Inapplicable

    Therapeutic Area : Oncology

    Highest Development Status : Approved FDF

    Recipient : SciGen

    Deal Size : Undisclosed

    Deal Type : Partnership

    DEALS_DEV arrow-down

    DKSH Has Successfully Entered into a Strategic Partnership with SciGen in Vietnam

    Details : DKSH has enetered a strategic partnership with SciGen to supply Zometa (zoledronic acid) to the Vietnamese market. it is indicated for the treatment of Advanced cancers.

    Product Name : Zometa

    Product Type : Miscellaneous

    Upfront Cash : Undisclosed

    July 21, 2023

    DKSH Company Banner

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow

    Virtual Booth

    • Deals
    • fda
    • EDQM
    • WHO-GMP
    Virtual BoothDKSH is your trusted partner for companies looking to grow their business in Asia & beyond.

    Nuance Pharma Announces Partnership With DKSH To Launch Bentrio™ Nasal Spray In Hong Kong And Macau

    Details:

    Under the cooperation agreement, DKSH HK will provide full-agency services including key account management, marketing promotion, supply chain, and distribution for Bentrio (bentonite) Nasal Spray sales operation in Hong Kong and Macau.


    Lead Product(s): Bentonite,Citric Acid,Propylene Glycol

    Therapeutic Area: Immunology Brand Name: Bentrio

    Study Phase: Approved FDFProduct Type: Miscellaneous

    Recipient: Nuance Pharma

    Deal Size: Undisclosed Upfront Cash: Undisclosed

    Deal Type: Partnership November 28, 2022

    DKSH Company Banner

    05

    DKSH

    Switzerland
    arrow
    CPhI WW Frankfurt
    Booth #8.0P66
    • fda
    • EDQM
    • WHO-GMP
    Virtual BoothDKSH is your trusted partner for companies looking to grow their business in Asia & beyond.

    Lead Product(s) : Bentonite,Citric Acid,Propylene Glycol

    Therapeutic Area : Immunology

    Highest Development Status : Approved FDF

    Recipient : Nuance Pharma

    Deal Size : Undisclosed

    Deal Type : Partnership

    DEALS_DEV arrow-down

    Nuance Pharma Announces Partnership With DKSH To Launch Bentrio™ Nasal Spray In Hong Kong And Ma...

    Details : Under the cooperation agreement, DKSH HK will provide full-agency services including key account management, marketing promotion, supply chain, and distribution for Bentrio (bentonite) Nasal Spray sales operation in Hong Kong and Macau.

    Product Name : Bentrio

    Product Type : Miscellaneous

    Upfront Cash : Undisclosed

    November 28, 2022

    DKSH Company Banner

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow

    Virtual Booth

    • Deals
    • fda
    • EDQM
    • WHO-GMP
    Virtual BoothDKSH is your trusted partner for companies looking to grow their business in Asia & beyond.

    Eisai To Divest Rights For Muscle Relaxant Myonal® And Vertigo And Equilibrium Disturbance Treatment Merislon® In Asia To DKSH

    Details:

    Myonal (eperisone hydrochloride) is a muscle-relaxant which is used to treat neck-shoulder-arm syndrome and Merislon is approved to treat vertigo and dizziness associated with inner-ear disorders.


    Lead Product(s): Eperisone Hydrochloride,Inapplicable

    Therapeutic Area: Neurology Brand Name: Myonal

    Study Phase: Approved FDFProduct Type: Miscellaneous

    Recipient: Eisai

    Deal Size: Undisclosed Upfront Cash: Undisclosed

    Deal Type: Agreement November 07, 2022

    DKSH Company Banner

    06

    DKSH

    Switzerland
    arrow
    CPhI WW Frankfurt
    Booth #8.0P66
    • fda
    • EDQM
    • WHO-GMP
    Virtual BoothDKSH is your trusted partner for companies looking to grow their business in Asia & beyond.

    Lead Product(s) : Eperisone Hydrochloride,Inapplicable

    Therapeutic Area : Neurology

    Highest Development Status : Approved FDF

    Recipient : Eisai

    Deal Size : Undisclosed

    Deal Type : Agreement

    DEALS_DEV arrow-down

    Eisai To Divest Rights For Muscle Relaxant Myonal® And Vertigo And Equilibrium Disturbance Treatm...

    Details : Myonal (eperisone hydrochloride) is a muscle-relaxant which is used to treat neck-shoulder-arm syndrome and Merislon is approved to treat vertigo and dizziness associated with inner-ear disorders.

    Product Name : Myonal

    Product Type : Miscellaneous

    Upfront Cash : Undisclosed

    November 07, 2022

    DKSH Company Banner

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow

    Virtual Booth

    • Deals
    • fda
    • EDQM
    • WHO-GMP
    Virtual BoothDKSH is your trusted partner for companies looking to grow their business in Asia & beyond.

    LEO Pharma and DKSH Partner to Deliver Products and Solutions to People in Asia with Skin Conditions and Thrombosis

    Details:

    The agreement will support both LEO Pharma’s strategy of building a simpler and more competitive organization and pipeline including its lead asset LP0133 (delgocitinib) and DKSH Business Unit Healthcare’s strategic focus of strengthening its regional footprint.


    Lead Product(s): Delgocitinib,Inapplicable

    Therapeutic Area: Dermatology Brand Name: Undisclosed

    Study Phase: Phase IIIProduct Type: Miscellaneous

    Recipient: Leo Pharma

    Deal Size: Undisclosed Upfront Cash: Undisclosed

    Deal Type: Partnership September 29, 2022

    DKSH Company Banner

    07

    DKSH

    Switzerland
    arrow
    CPhI WW Frankfurt
    Booth #8.0P66
    • fda
    • EDQM
    • WHO-GMP
    Virtual BoothDKSH is your trusted partner for companies looking to grow their business in Asia & beyond.

    Lead Product(s) : Delgocitinib,Inapplicable

    Therapeutic Area : Dermatology

    Highest Development Status : Phase III

    Recipient : Leo Pharma

    Deal Size : Undisclosed

    Deal Type : Partnership

    DEALS_DEV arrow-down

    LEO Pharma and DKSH Partner to Deliver Products and Solutions to People in Asia with Skin Conditio...

    Details : The agreement will support both LEO Pharma’s strategy of building a simpler and more competitive organization and pipeline including its lead asset LP0133 (delgocitinib) and DKSH Business Unit Healthcare’s strategic focus of strengthening its regiona...

    Product Name : Undisclosed

    Product Type : Miscellaneous

    Upfront Cash : Undisclosed

    September 29, 2022

    DKSH Company Banner

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow

    Virtual Booth

    • Deals
    • fda
    • EDQM
    • WHO-GMP
    Virtual BoothDKSH is your trusted partner for companies looking to grow their business in Asia & beyond.

    Lupin and DKSH Sign an Exclusive Licensing and Supply Agreement to Market Five Biosimilar Candidates in the Philippines

    Details:

    The biosimilars planned under this agreement include biosimilar of Prolia® (denosumab, AVT03), Xgeva® (denosumab), Simponi® (golimumab), and Eylea® (aflibercept) as well as two undisclosed proposed biosimilars for immunology and oncology.


    Lead Product(s): Denosumab,Inapplicable

    Therapeutic Area: Musculoskeletal Brand Name: Undisclosed

    Study Phase: Phase IIIProduct Type: Antibody, Unconjugated

    Recipient: Lupin Ltd

    Deal Size: Undisclosed Upfront Cash: Undisclosed

    Deal Type: Licensing Agreement September 07, 2022

    DKSH Company Banner

    08

    DKSH

    Switzerland
    arrow
    CPhI WW Frankfurt
    Booth #8.0P66
    • fda
    • EDQM
    • WHO-GMP
    Virtual BoothDKSH is your trusted partner for companies looking to grow their business in Asia & beyond.

    Lead Product(s) : Denosumab,Inapplicable

    Therapeutic Area : Musculoskeletal

    Highest Development Status : Phase III

    Recipient : Lupin Ltd

    Deal Size : Undisclosed

    Deal Type : Licensing Agreement

    DEALS_DEV arrow-down

    Lupin and DKSH Sign an Exclusive Licensing and Supply Agreement to Market Five Biosimilar Candidat...

    Details : The biosimilars planned under this agreement include biosimilar of Prolia® (denosumab, AVT03), Xgeva® (denosumab), Simponi® (golimumab), and Eylea® (aflibercept) as well as two undisclosed proposed biosimilars for immunology and oncology.

    Product Name : Undisclosed

    Product Type : Antibody, Unconjugated

    Upfront Cash : Undisclosed

    September 07, 2022

    DKSH Company Banner

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow

    Virtual Booth

    • Deals
    • fda
    • EDQM
    • WHO-GMP
    Virtual BoothDKSH is your trusted partner for companies looking to grow their business in Asia & beyond.

    Alvotech and DKSH partner to bring key biosimilar to Asia

    Details:

    Under the partnership, Alvotech Hf will be responsible for the development and supply of AVT02, while DKSH will oversee its registration and commercialization.


    Lead Product(s): Adalimumab,Inapplicable

    Therapeutic Area: Immunology Brand Name: Simlandi

    Study Phase: Phase IIIProduct Type: Antibody, Unconjugated

    Recipient: Alvotech

    Deal Size: Undisclosed Upfront Cash: Undisclosed

    Deal Type: Partnership March 24, 2020

    DKSH Company Banner

    09

    DKSH

    Switzerland
    arrow
    CPhI WW Frankfurt
    Booth #8.0P66
    • fda
    • EDQM
    • WHO-GMP
    Virtual BoothDKSH is your trusted partner for companies looking to grow their business in Asia & beyond.

    Lead Product(s) : Adalimumab,Inapplicable

    Therapeutic Area : Immunology

    Highest Development Status : Phase III

    Recipient : Alvotech

    Deal Size : Undisclosed

    Deal Type : Partnership

    DEALS_DEV arrow-down

    Alvotech and DKSH partner to bring key biosimilar to Asia

    Details : Under the partnership, Alvotech Hf will be responsible for the development and supply of AVT02, while DKSH will oversee its registration and commercialization.

    Product Name : Simlandi

    Product Type : Antibody, Unconjugated

    Upfront Cash : Undisclosed

    March 24, 2020

    DKSH Company Banner

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow

    Virtual Booth

    Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

    KEY PRODUCTS

    read-more
    read-more

    TOP RANKED SUPPLIER FOR:
    Sponsored Ads.full-view
    Sponsored Ads.full-view
    Sponsored Ads.full-view
    Sponsored Ads.full-view
    Sponsored Ads.full-view
    Sponsored Ads.full-view

    Excipients

    Discover the DDS // excipients from this company

    KEY EXCIPIENTS

    read-more
    read-more

    TOP RANKED SUPPLIER FOR:

    DKSH full-view
    Blanose CMC 7LP EP
    full-view
    Blanose CMC 7LP EP
    full-view
    Aquapol® SF-1
    full-view

    Excipients by Ingredients

    Discover their expertise by components

    Excipients By applications

    Discover their expertise by claims

    Inspections and registrations

    Check the inspections & registration from this company

    ABOUT THIS PAGE

    Contact DKSH and get a quotation

    DKSH is a supplier offers 115 products (APIs, Excipients or Intermediates).

    Find a price of Ajmaline bulk offered by DKSH

    Find a price of Alpha Lipoic Acid bulk offered by DKSH

    Find a price of Aluminium Hydroxide bulk offered by DKSH

    Find a price of Amiodarone Hydrochloride bulk offered by DKSH

    Find a price of Apixaban bulk offered by DKSH

    Find a price of Artemether bulk offered by DKSH

    Find a price of Aspirin bulk offered by DKSH

    Find a price of Atorvastatin bulk offered by DKSH

    Find a price of Atracurium Besylate bulk offered by DKSH

    Find a price of Avermectin bulk offered by DKSH

    Find a price of Azacitidine bulk offered by DKSH

    Find a price of Azathioprine bulk offered by DKSH

    Find a price of Azithromycin bulk offered by DKSH

    Find a price of Baloxavir Marboxil bulk offered by DKSH

    Find a price of Bortezomib bulk offered by DKSH

    Find a price of Bromhexine Hydrochloride bulk offered by DKSH

    Find a price of Budesonide bulk offered by DKSH

    Find a price of Carbamazepine bulk offered by DKSH

    Find a price of Carfilzomib bulk offered by DKSH

    Find a price of Carvedilol bulk offered by DKSH

    Find a price of Caspofungin bulk offered by DKSH

    Find a price of Chlorhexidine Gluconate bulk offered by DKSH

    Find a price of Cimetropium Bromide bulk offered by DKSH

    Find a price of Citicoline Sodium bulk offered by DKSH

    Find a price of Clarithromycin bulk offered by DKSH

    Find a price of Colchicine bulk offered by DKSH

    Find a price of Deferasirox bulk offered by DKSH

    Find a price of Desloratadine bulk offered by DKSH

    Find a price of Dexamethasone bulk offered by DKSH

    Find a price of Diclofenac Sodium bulk offered by DKSH

    Find a price of Dienogest bulk offered by DKSH

    Find a price of Digoxin bulk offered by DKSH

    Find a price of Diisopropylamine Dichloroacetate bulk offered by DKSH

    Find a price of Diphenhydramine Hydrochloride bulk offered by DKSH

    Find a price of Doxazosin Mesylate bulk offered by DKSH

    Find a price of Doxorubicin Hydrochloride bulk offered by DKSH

    Find a price of Doxycycline bulk offered by DKSH

    Find a price of Doxycycline Hyclate bulk offered by DKSH

    Find a price of Drospirenone bulk offered by DKSH

    Find a price of Emtricitabine bulk offered by DKSH

    Find a price of Epirubicin Hydrochloride bulk offered by DKSH

    Find a price of Erythromycin bulk offered by DKSH

    Find a price of Everolimus bulk offered by DKSH

    Find a price of Ezetimibe bulk offered by DKSH

    Find a price of Fluocinolone Acetonide bulk offered by DKSH

    Find a price of Guaifenesin bulk offered by DKSH

    Find a price of Haloperidol bulk offered by DKSH

    Find a price of Icosapent Ethyl bulk offered by DKSH

    Find a price of Indacaterol Maleate bulk offered by DKSH

    Find a price of Itraconazole bulk offered by DKSH

    Find a price of Ivermectin bulk offered by DKSH

    Find a price of Ketotifen Fumarate bulk offered by DKSH

    Find a price of Lamivudine bulk offered by DKSH

    Find a price of Lamotrigine bulk offered by DKSH

    Find a price of Levocetirizine Dihydrochloride bulk offered by DKSH

    Find a price of Levofloxacin bulk offered by DKSH

    Find a price of Levofloxacin Hemihydrate bulk offered by DKSH

    Find a price of Lidamidine Hydrochloride bulk offered by DKSH

    Find a price of Lidocaine bulk offered by DKSH

    Find a price of Loratadine bulk offered by DKSH

    Find a price of Magaldrate bulk offered by DKSH

    Find a price of Magnesium Hydroxide bulk offered by DKSH

    Find a price of Metaxalone bulk offered by DKSH

    Find a price of Methocarbamol bulk offered by DKSH

    Find a price of Methscopolamine Bromide bulk offered by DKSH

    Find a price of Methyl Salicylate bulk offered by DKSH

    Find a price of Metronidazole bulk offered by DKSH

    Find a price of Miconazole Nitrate bulk offered by DKSH

    Find a price of Mometasone Furoate bulk offered by DKSH

    Find a price of Mosapride Citrate bulk offered by DKSH

    Find a price of Moxifloxacin Hydrochloride bulk offered by DKSH

    Find a price of Mycophenolate Mofetil bulk offered by DKSH

    Find a price of Mycophenolate Mofetil Hydrochloride bulk offered by DKSH

    Find a price of Neomycin Sulfate bulk offered by DKSH

    Find a price of Nicorandil bulk offered by DKSH

    Find a price of Noscapine bulk offered by DKSH

    Find a price of Noscapine Hydrochloride bulk offered by DKSH

    Find a price of Olanzapine bulk offered by DKSH

    Find a price of Omega-3-Carboxylic Acids bulk offered by DKSH

    Find a price of Omeprazole bulk offered by DKSH

    Find a price of Paclitaxel bulk offered by DKSH

    Find a price of Pantoprazole Sodium bulk offered by DKSH

    Find a price of Papaverine Hydrochloride bulk offered by DKSH

    Find a price of Paracetamol bulk offered by DKSH

    Find a price of Paroxetine Hydrochloride bulk offered by DKSH

    Find a price of Pentosan Polysulfate Sodium bulk offered by DKSH

    Find a price of Pheniramine Maleate bulk offered by DKSH

    Find a price of Pranlukast Hydrate bulk offered by DKSH

    Find a price of Prednisone bulk offered by DKSH

    Find a price of Procaine bulk offered by DKSH

    Find a price of Quetiapine Hemifumarate bulk offered by DKSH

    Find a price of Rabeprazole Sodium bulk offered by DKSH

    Find a price of Racecadotril bulk offered by DKSH

    Find a price of Reserpine bulk offered by DKSH

    Find a price of Rosuvastatin Calcium bulk offered by DKSH

    Find a price of Ruxolitinib Phosphate bulk offered by DKSH

    Find a price of Salbutamol Sulphate bulk offered by DKSH

    Find a price of Scopolamine bulk offered by DKSH

    Find a price of Scopolamine Hydrobromide bulk offered by DKSH

    Find a price of Sirolimus bulk offered by DKSH

    Find a price of Sugammadex Sodium bulk offered by DKSH

    Find a price of Tacrolimus bulk offered by DKSH

    Find a price of Tadalafil bulk offered by DKSH

    Find a price of Tamsulosin bulk offered by DKSH

    Find a price of Telmisartan bulk offered by DKSH

    Find a price of Tenofovir Alafenamide Fumarate bulk offered by DKSH

    Find a price of Tenofovir Disoproxil Fumarate bulk offered by DKSH

    Find a price of Tenoxicam bulk offered by DKSH

    Find a price of Terbinafine bulk offered by DKSH

    Find a price of Terbinafine Hydrochloride bulk offered by DKSH

    Find a price of Thiocolchicoside bulk offered by DKSH

    Find a price of Ulipristal Acetate bulk offered by DKSH

    Find a price of Vildagliptin bulk offered by DKSH

    Find a price of Vonoprazan Fumarate bulk offered by DKSH

    Find a price of Zoledronic Acid bulk offered by DKSH

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search